Vascular tissue engineering: The next generation

Trends in Molecular Medicine

Volumn 18, Issue 7, 2012, Pages 394-404

  Cleary, Muriel A ^a   Geiger, Erik ^a   Grady, Conor ^a   Best, Cameron ^a   Naito, Yuji ^a   Breuer, Christopher ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biodegradable scaffold; Blood vessels; Bypass surgery; Stem cells; Stenosis; Tissue engineered vascular graft

Indexed keywords

CALPONIN; CARBON DIOXIDE; CD31 ANTIGEN; CD68 ANTIGEN; COLLAGEN; COLLAGEN FIBER; ELASTIN; FIBRIN; FIBRONECTIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; LIPID; MOLECULAR SCAFFOLD; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROUS OXIDE; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; PROTEOGLYCAN; SMOOTH MUSCLE ACTIN; VON WILLEBRAND FACTOR; WARFARIN; WATER;

ANGIOPLASTY; ANTICOAGULATION; ARTERIAL PRESSURE; ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT; ARTERY DIAMETER; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; B LYMPHOCYTE; BIODEGRADABLE IMPLANT; BIOREACTOR; BLOOD VESSEL GRAFT; BONE MARROW CELL; BRAIN HEMORRHAGE; CARDIOVASCULAR SYSTEM; CAVOPULMONARY CONNECTION; CELL CYCLE; CELL ENCAPSULATION; CELL GROWTH; CELL MIGRATION; CELL POPULATION; CELL STRUCTURE; CROSS LINKING; DRUG WITHDRAWAL; ELASTICITY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMOROPOPLITEAL BYPASS; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GIANT CELL; GRAFT FAILURE; GRAFT PATENCY; HEART ARRHYTHMIA; HEART FAILURE; HEART SINGLE VENTRICLE; HEMODIALYSIS PATIENT; HUMAN; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFERIOR CAVA VEIN; LAMB; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; MORTALITY; NONHUMAN; PARACRINE SIGNALING; POLITEF IMPLANT; PROTEIN POLYMERIZATION; REVIEW; STENOSIS; STENT; T LYMPHOCYTE; TENSILE STRENGTH; THROMBOSIS; TISSUE ENGINEERING; TISSUE GROWTH; VEIN GRAFT; Y CHROMOSOME;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; BONE MARROW CELLS; HUMANS; MODELS, ANIMAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84863106778     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.04.013     Document Type: Review

References (92)

1. Principles of Tissue Engineering 2007, Academic Press. R.P. Lanza, J. Vacanti (Eds.).
2. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
3. Edelman E.R. Vascular tissue engineering: designer arteries. Circ. Res. 1999, 85:1115.
4. Nerem R.M., Seliktar D. Vascular tissue engineering. Annu. Rev. Biomed. Eng. 2001, 3:225-243.
5. Shinoka T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J. Thorac. Cardiovasc. Surg. 2005, 129:1330-1338.
6. Shinoka T. Clinical results of tissue-engineered vascular autografts seeded with autologous bone marrow cells. Nippon Geka Gakkai Zasshi 2004, 105:459-463.
7. Hibino N., et al. Late-term results of tissue-engineered vascular grafts in humans. J. Thorac. Cardiovasc. Surg. 2010, 139:431-436. 436.e1-2.
8. Schneider P.A., et al. Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons. J. Vasc. Surg. 1988, 8:229-235.
9. Clowes A.W., et al. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am. J. Pathol. 1986, 123:220-230.
10. Herring M., et al. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978, 84:498-504.
11. Herring M., et al. Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: the failure of low-density seeding to improve patency. J. Vasc. Surg. 1994, 20:650-655.
12. Rosenman J.E., et al. Kinetics of endothelial cell seeding. J. Vasc. Surg. 1985, 2:778-784.
13. Mazzucotelli J.P., et al. Human vascular endothelial cells on expanded PTFE precoated with an engineered protein adhesion factor. Int. J. Artif. Organs 1994, 17:112-117.
14. Nishibe T., et al. Effects of fibronectin bonding on healing of high porosity expanded polytetrafluoroethylene grafts in pigs. J. Cardiovasc. Surg. (Torino) 2001, 42:667-673.
15. Krijgsman B., et al. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: its role in enhancing cellular retention. Tissue Eng. 2002, 8:673-680.
16. Deutsch M., et al. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999, 126:847-855.
17. Zilla P., et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J. Vasc. Surg. 1994, 19:540-548.
18. Deutsch M., et al. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J. Vasc. Surg. 2009, 49:352-362. discussion 362.
19. L'Heureux N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 2006, 12:361-365.
20. L'Heureux N., et al. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J. Vasc. Surg. 1993, 17:499-509.
21. Hirai J., et al. Highly oriented, tubular hybrid vascular tissue for a low pressure circulatory system. ASAIO J. 1994, 40:M383-M388.
22. Barocas V.H., et al. Engineered alignment in media equivalents: magnetic prealignment and mandrel compaction. J. Biomech. Eng. 1998, 120:660-666.
23. Girton T.S., et al. Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. J. Biomech. Eng. 2000, 122:216-223.
24. Seliktar D., et al. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann. Biomed. Eng. 2000, 28:351-362.
25. Kanda K., et al. Mechanical stress induced cellular orientation and phenotypic modulation of 3-D cultured smooth muscle cells. ASAIO J. 1993, 39:M686-M690.
26. Kanda K., Matsuda T. Mechanical stress-induced orientation and ultrastructural change of smooth muscle cells cultured in three-dimensional collagen lattices. Cell Transplant. 1994, 3:481-492.
27. Cummings C.L., et al. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004, 25:3699-3706.
28. Swartz D.D., et al. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H1451-H1460.
29. Buijtenhuijs P., et al. Tissue engineering of blood vessels: characterization of smooth-muscle cells for culturing on collagen-and-elastin-based scaffolds. Biotechnol. Appl. Biochem. 2004, 39:141-149.
30. Nagapudi K., et al. Viscoelastic and mechanical behavior of recombinant protein elastomers. Biomaterials 2005, 26:4695-4706.
31. Ye Q., et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 2000, 17:587-591.
32. Jockenhoevel S., et al. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 2001, 19:424-430.
33. Syedain Z.H., et al. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011, 32:714-722.
34. Bjork J.W., et al. Hypoxic culture and insulin yield improvements to fibrin-based engineered tissue. Tissue Eng. A 2012, 18:785-795.
35. L'Heureux N., et al. A completely biological tissue-engineered human blood vessel. FASEB J. 1998, 12:47-56.
36. L'Heureux N., et al. Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med. 2007, 357:1451-1453.
37. McAllister T.N., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009, 373:1440-1446.
38. Mooney D.J., et al. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials 1996, 17:115-124.
39. Hutmacher D.W., et al. An introduction to biodegradable materials for tissue engineering applications. Ann. Acad. Med. Singapore 2001, 30:183-191.
40. Ravi S., Chaikof E.L. Biomaterials for vascular tissue engineering. Regen. Med. 2010, 5:107-120.
41. Niklason L.E., et al. Functional arteries grown in vitro. Science 1999, 284:489-493.
42. Shum-Tim D., et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac. Surg. 1999, 68:2298-2304. discussion 2305.
43. Dahl S.L.M., et al. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003, 12:659-666.
44. Tamura N., et al. A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int. J. Artif. Organs 2003, 26:783-792.
45. Uchimura E., et al. Novel method of preparing acellular cardiovascular grafts by decellularization with poly(ethylene glycol). J. Biomed. Mater. Res. A 2003, 67:834-837.
46. Sandusky G.E., et al. Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am. J. Pathol. 1992, 140:317-324.
47. Sandusky G.E., et al. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J. Surg. Res. 1995, 58:415-420.
48. Roeder R., et al. Compliance, elastic modulus, and burst pressure of small-intestine submucosa (SIS), small-diameter vascular grafts. J. Biomed. Mater. Res. 1999, 47:65-70.
49. Sala Almonacil V., et al. Comparison between autogenous brachial-basilic upper arm transposition fistulas and prosthetic brachial-axillary vascular accesses for hemodialysis. J. Cardiovasc. Surg. (Torino) 2011, 52:725-730.
50. Fitzgerald J.T., et al. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch. Surg. 2004, 139:201-208.
51. Wystrychowski W., et al. Case study: first implantation of a frozen, devitalized tissue-engineered vascular graft for urgent hemodialysis access. J. Vasc. Access 2011, 12:67-70.
52. Shinoka T., et al. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 2001, 344:532-533.
53. Shinoka T., et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 1995, 60:S513-S516.
54. Breuer C.K., et al. Tissue engineering lamb heart valve leaflets. Biotechnol. Bioeng. 1996, 50:562-567.
55. Shinoka T., et al. Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 1998, 115:536-545. discussion 545-546.
56. Watanabe M., et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001, 7:429-439.
57. Hibino N., et al. First successful clinical application of tissue engineered blood vessel. Kyobu Geka 2002, 55:368-373.
58. Matsumura G., et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003, 108:1729-1734.
59. Shinoka T., Breuer C. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J. Biol. Med. 2008, 81:161-166.
60. Nelson G.N., et al. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings. Arch. Surg. 2008, 143:488-494.
61. Lopez-Soler R.I., et al. Development of a mouse model for evaluation of small diameter vascular grafts. J. Surg. Res. 2007, 139:1-6.
62. Rashid S.T., et al. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 2004, 25:1627-1637.
63. Goyal A., et al. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. J. Pediatr. Surg. 2006, 41:787-791.
64. Roh J.D., et al. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 2008, 29:1454-1463.
65. Hibino N., et al. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 2011, 25:2731-2739.
66. Roh J.D., et al. Centrifugal seeding increases seeding efficiency and cellular distribution of bone marrow stromal cells in porous biodegradable scaffolds. Tissue Eng. 2007, 13:2743-2749.
67. Roh J.D., et al. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques. J. Pediatr. Surg. 2007, 42:198-202.
68. Brennan M.P., et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann. Surg. 2008, 248:370-377.
69. Noishiki Y., et al. Choice, isolation, and preparation of cells for bioartificial vascular grafts. Artif. Organs 1998, 22:50-62.
70. Villalona G.A., et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng. B: Rev. 2010, 16:341-350.
71. Mirensky T.L., et al. Tissue-engineered vascular grafts: does cell seeding matter?. J. Pediatr. Surg. 2010, 45:1299-1305.
72. Naito Y., et al. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs 2012, 195:60-72.
73. Roh J.D., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4669-4674.
74. Ziegelhoeffer T., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 2004, 94:230-238.
75. Zentilin L., et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006, 107:3546-3554.
76. Abbott W.M., et al. Evaluation and performance standards for arterial prostheses. J. Vasc. Surg. 1993, 17:746-756.
77. Hjortnaes J., et al. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. Tissue Eng. C: Methods 2010, 16:597-607.
78. Hibino N., et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 2011, 25:4253-4263.
79. Wu M.H., et al. The direct effect of graft compliance mismatch per se on development of host arterial intimal hyperplasia at the anastomotic interface. Ann. Vasc. Surg. 1993, 7:156-168.
80. Kamiya A., Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am. J. Physiol. 1980, 239:H14-H21.
81. Inoguchi H., et al. Mechanical responses of a compliant electrospun poly(L-lactide-co-epsilon-caprolactone) small-diameter vascular graft. Biomaterials 2006, 27:1470-1478.
82. Vaz C.M., et al. Design of scaffolds for blood vessel tissue engineering using a multi-layering electrospinning technique. Acta Biomater. 2005, 1:575-582.
83. Murugan R., Ramakrishna S. Design strategies of tissue engineering scaffolds with controlled fiber orientation. Tissue Eng. 2007, 13:1845-1866.
84. Pham Q.P., et al. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng. 2006, 12:1197-1211.
85. Bondar B., et al. Functionality of endothelial cells on silk fibroin nets: comparative study of micro- and nanometric fibre size. Biomaterials 2008, 29:561-572.
86. Danenberg H.D., et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 2002, 106:599-605.
87. Bergmann C.E., et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J. Leukoc. Biol. 2006, 80:59-65.
88. Arras M., et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 1998, 101:40-50.
89. Halme D. FDA regulation of stem-cell-based therapies. N. Engl. J. Med. 2006, 355:1730-1735.
90. Breuer C.K. The development and translation of the tissue-engineered vascular graft. J. Pediatr. Surg. 2011, 46:8-17.
91. Hoerstrup S.P., et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006, 114:I159-I166.
92. Harrington J.K., et al. Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. FASEB J. 2011, 25:4150-4161.